Skip to main content

Table 2 Metastasis site

From: Bevacizumab based chemotherapy in first line treatment of HER2 negative metastatic breast cancer: results of a Moroccan observational institutional study

Metastasis site

Number of patients

Bone

12 (63.1%)

Liver

9 (47.3%)

Lung

9 (47.3%)

Local recurrence

5 (26.3%)

Lymph nods

4 (21%)

Contralateral recurrence

3 (15.7%)

Brain

1 (5.2%)

Back to article page

BMC Research Notes

ISSN: 1756-0500

Contact us